Search filters

List of works by Freek W A Verheugt

2012 focused update of the ESC Guidelines for the management of atrial fibrillation ⬇️

scientific article published on August 24, 2012

A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

scientific article published on 11 November 2019

Aborted myocardial infarction: a new target for reperfusion therapy

scientific article

Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012

Anticoagulants in heart disease: current status and perspectives

scientific article published on 10 April 2007

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

scientific article published on 2 March 2018

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

scientific article published on 09 July 2015

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial

scientific article published in August 2015

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

scientific article published in March 2010

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

scientific article

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 20 October 2013

Apixaban with antiplatelet therapy after acute coronary syndrome

scientific article

Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis

scientific article published on July 2014

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

scientific article (publication date: December 2003)

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

scientific article

Cardioversion as bystander in atrial fibrillation-related thrombo-embolism

scientific article published on 01 September 2019

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

scientific article published on 4 February 2016

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

scientific article published on 4 February 2016

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

scientific article published on 12 December 2014

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

scientific article published on 11 June 2015

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

scientific article published on 17 January 2017

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)

Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

scientific article (publication date: August 2003)

GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke

scientific article published on 22 July 2020

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 28 February 2013

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

scientific article published on 31 August 2008

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction.

scientific article published on 29 August 2013

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial

scientific article published on 01 April 2019

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

scientific article published on 01 July 2019

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction

scientific article published on 17 July 2012

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

scientific article

Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.

scientific article

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

scientific article

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis

scientific article published on 26 February 2020

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

scientific article published on 8 March 2016

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

scientific article published in October 2003

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

scientific article published on 20 December 2019

Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial

scientific article published on 10 November 2017

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

scientific article published on 15 June 2016

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial

scientific article published on 30 December 2019

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular

scientific article published on 24 December 2015

Rivaroxaban Plasma Levels and Levetiracetam

scientific article published on 01 November 2020

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials

scientific article published on 19 June 2019

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations

scientific article published on 31 December 2018

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial

scientific article published on 25 May 2007

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013

Paulina is supported by:

About Paulina

Help